IL204127A - Thadiazinone derivatives - Google Patents
Thadiazinone derivativesInfo
- Publication number
- IL204127A IL204127A IL204127A IL20412710A IL204127A IL 204127 A IL204127 A IL 204127A IL 204127 A IL204127 A IL 204127A IL 20412710 A IL20412710 A IL 20412710A IL 204127 A IL204127 A IL 204127A
- Authority
- IL
- Israel
- Prior art keywords
- denotes
- salts
- solvates
- stereoisomers
- ratios
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102007041115A DE102007041115A1 (de) | 2007-08-30 | 2007-08-30 | Thiadiazinonderivate |
| PCT/EP2008/006466 WO2009030333A1 (de) | 2007-08-30 | 2008-08-06 | Thiadiazinonderivate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL204127A true IL204127A (en) | 2013-08-29 |
Family
ID=39952448
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL204127A IL204127A (en) | 2007-08-30 | 2010-02-23 | Thadiazinone derivatives |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US8211886B2 (enExample) |
| EP (1) | EP2181111B1 (enExample) |
| JP (1) | JP5524840B2 (enExample) |
| KR (1) | KR20100065171A (enExample) |
| CN (1) | CN101784544B (enExample) |
| AR (1) | AR068130A1 (enExample) |
| AU (1) | AU2008295193B2 (enExample) |
| BR (1) | BRPI0816058A2 (enExample) |
| CA (1) | CA2698062C (enExample) |
| DE (1) | DE102007041115A1 (enExample) |
| EA (1) | EA017393B1 (enExample) |
| ES (1) | ES2426356T3 (enExample) |
| IL (1) | IL204127A (enExample) |
| MX (1) | MX2010002096A (enExample) |
| WO (1) | WO2009030333A1 (enExample) |
| ZA (1) | ZA201002218B (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2013532627A (ja) | 2010-07-01 | 2013-08-19 | 武田薬品工業株式会社 | ｃＭＥＴ阻害剤とＨＧＦおよび／またはｃＭＥＴに対する抗体との組み合わせ |
| EP3229836B1 (en) | 2014-12-09 | 2019-11-13 | Institut National de la Sante et de la Recherche Medicale (INSERM) | Human monoclonal antibodies against axl |
| WO2016135041A1 (en) | 2015-02-26 | 2016-09-01 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Fusion proteins and antibodies comprising thereof for promoting apoptosis |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5795964A (en) | 1980-12-04 | 1982-06-15 | Morishita Seiyaku Kk | Preparation of 2-substituted-3(2h)-pyridazinone derivative |
| US4397854A (en) | 1981-05-14 | 1983-08-09 | Warner-Lambert Company | Substituted 6-phenyl-3(2H)-pyridazinones useful as cardiotonic agents |
| DE4310699A1 (de) * | 1993-04-01 | 1994-10-06 | Merck Patent Gmbh | Thiadiazinone |
| AU691673B2 (en) | 1994-11-14 | 1998-05-21 | Dow Agrosciences Llc | Pyridazinones and their use as fungicides |
| US5635494A (en) | 1995-04-21 | 1997-06-03 | Rohm And Haas Company | Dihydropyridazinones and pyridazinones and their use as fungicides and insecticides |
| GB9624482D0 (en) | 1995-12-18 | 1997-01-15 | Zeneca Phaema S A | Chemical compounds |
| DE19604388A1 (de) | 1996-02-07 | 1997-08-14 | Merck Patent Gmbh | Arylalkyl-diazinone |
| WO1997030035A1 (en) | 1996-02-13 | 1997-08-21 | Zeneca Limited | Quinazoline derivatives as vegf inhibitors |
| ES2169355T3 (es) | 1996-03-05 | 2002-07-01 | Astrazeneca Ab | Derivados de 4-anilinoquinazolina. |
| GB9718972D0 (en) | 1996-09-25 | 1997-11-12 | Zeneca Ltd | Chemical compounds |
| GB9714249D0 (en) | 1997-07-08 | 1997-09-10 | Angiogene Pharm Ltd | Vascular damaging agents |
| EP2017266A1 (en) | 1997-11-19 | 2009-01-21 | Kowa Co., Ltd. | Pyridazine derivatives and medicines containing the same as effective ingredients |
| TWI241295B (en) | 1998-03-02 | 2005-10-11 | Kowa Co | Pyridazine derivative and medicine containing the same as effect component |
| GB9900334D0 (en) | 1999-01-07 | 1999-02-24 | Angiogene Pharm Ltd | Tricylic vascular damaging agents |
| GB9900752D0 (en) | 1999-01-15 | 1999-03-03 | Angiogene Pharm Ltd | Benzimidazole vascular damaging agents |
| IL152682A0 (en) | 2000-05-31 | 2003-06-24 | Astrazeneca Ab | Indole derivatives with vascular damaging activity |
| HUP0301742A3 (en) | 2000-07-07 | 2005-08-29 | Angiogene Pharm Ltd | Colchinol derivatives as angiogenesis inhibitors, process for producing them, pharmaceutical compositions containing them and their use |
| BR0112224A (pt) | 2000-07-07 | 2003-06-10 | Angiogene Pharm Ltd | Composto, composição farmacêutica, uso de um composto ou de um sal, solvato ou pró-droga farmaceuticamente aceitável do mesmo, e, processo para preparar um composto |
| US20040259863A1 (en) | 2001-10-31 | 2004-12-23 | Hans-Michael Eggenweiler | Type 4 phosphodiesterase inhibitors and uses thereof |
| DE102005055355A1 (de) | 2005-11-21 | 2007-10-31 | Merck Patent Gmbh | 3,6-Dihydro-2-oxo-6H-[1,3,4]thiadiazinderivate |
| DE102005055354A1 (de) | 2005-11-21 | 2007-10-31 | Merck Patent Gmbh | Substituierte 5-Phenyl-3,6-dihydro-2-oxo-6H-[1,3,4]thiadiazine |
| DE102006037478A1 (de) * | 2006-08-10 | 2008-02-14 | Merck Patent Gmbh | 2-(Heterocyclylbenzyl)-pyridazinonderivate |
| DE102007032507A1 (de) * | 2007-07-12 | 2009-04-02 | Merck Patent Gmbh | Pyridazinonderivate |
-
2007
- 2007-08-30 DE DE102007041115A patent/DE102007041115A1/de not_active Withdrawn
-
2008
- 2008-08-06 JP JP2010522210A patent/JP5524840B2/ja not_active Expired - Fee Related
- 2008-08-06 BR BRPI0816058 patent/BRPI0816058A2/pt not_active IP Right Cessation
- 2008-08-06 ES ES08785386T patent/ES2426356T3/es active Active
- 2008-08-06 MX MX2010002096A patent/MX2010002096A/es active IP Right Grant
- 2008-08-06 CN CN2008801040992A patent/CN101784544B/zh not_active Expired - Fee Related
- 2008-08-06 EA EA201000364A patent/EA017393B1/ru not_active IP Right Cessation
- 2008-08-06 EP EP08785386.7A patent/EP2181111B1/de active Active
- 2008-08-06 KR KR1020107006823A patent/KR20100065171A/ko not_active Withdrawn
- 2008-08-06 WO PCT/EP2008/006466 patent/WO2009030333A1/de not_active Ceased
- 2008-08-06 AU AU2008295193A patent/AU2008295193B2/en not_active Ceased
- 2008-08-06 CA CA2698062A patent/CA2698062C/en active Active
- 2008-08-06 US US12/675,412 patent/US8211886B2/en not_active Expired - Fee Related
- 2008-08-29 AR ARP080103757A patent/AR068130A1/es unknown
-
2010
- 2010-02-23 IL IL204127A patent/IL204127A/en active IP Right Grant
- 2010-03-29 ZA ZA2010/02218A patent/ZA201002218B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EA201000364A1 (ru) | 2010-08-30 |
| US8211886B2 (en) | 2012-07-03 |
| CN101784544A (zh) | 2010-07-21 |
| EP2181111A1 (de) | 2010-05-05 |
| ES2426356T3 (es) | 2013-10-22 |
| DE102007041115A1 (de) | 2009-03-05 |
| MX2010002096A (es) | 2010-03-26 |
| CA2698062A1 (en) | 2009-03-12 |
| AU2008295193A1 (en) | 2009-03-12 |
| CA2698062C (en) | 2016-05-31 |
| JP2010536896A (ja) | 2010-12-02 |
| KR20100065171A (ko) | 2010-06-15 |
| WO2009030333A1 (de) | 2009-03-12 |
| EA017393B1 (ru) | 2012-12-28 |
| BRPI0816058A2 (pt) | 2015-03-31 |
| JP5524840B2 (ja) | 2014-06-18 |
| AR068130A1 (es) | 2009-11-04 |
| AU2008295193B2 (en) | 2013-04-18 |
| EP2181111B1 (de) | 2013-06-26 |
| ZA201002218B (en) | 2010-12-29 |
| US20100311733A1 (en) | 2010-12-09 |
| CN101784544B (zh) | 2012-08-29 |
| HK1146276A1 (en) | 2011-05-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8859547B2 (en) | Pyridazinone derivatives | |
| CA2721858C (en) | Pyridazinone derivatives | |
| CA2728194C (en) | 3-(3-pyrimidin-2-ylbenzyl)-1,2,4-triazolo[4,3-b]pyridazine derivatives as met kinase inhibitors | |
| AU2008274534A1 (en) | Pyrimidinyl-pyridazinone derivatives | |
| IL202603A (en) | The composition of a pharmacy containing 1} (isobutanoyloxyethoxy) carbonyl] aminomethyl {-1-cyclohexane crystalline acetic acid, and its composition is acceptable and its use in the preparation of a drug | |
| US9376426B2 (en) | Pyridazinone derivatives | |
| CA2696472A1 (en) | 6-thioxopyridazine derivatives | |
| IL191361A (en) | Compounds Containing 6,3-Dihydro-2-Oxo-H6- [1,3,4] Thyadiazines | |
| IL191360A (en) | Compounds Containing 5-Phenyl-6,3-Dihydro-2-Oxo-H6- [1,3,4] Thadiazines Converted, Process for their Preparation and Use for Drug Preparation | |
| AU2009336847B2 (en) | Benzothiazolone derivative | |
| AU2009328730B2 (en) | 3-(3-Pyrimidin-2-yl-benzyl)-[1,2,4]triazolo[4,3-B]pyrimidine derivatives | |
| US8211886B2 (en) | Thiadiazinone derivatives | |
| CA2747932C (en) | 3-(3-pyrimidin-2-ylbenzyl)-1,2,4-triazolo[4,3-b]pyridazine derivatives | |
| CA2726009A1 (en) | Dihydropyrazole derivatives as tyrosine kinase modulators for the treatment of tumours |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed |